Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging
- PMID: 20032150
- DOI: 10.1148/radiol.09090304
Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging
Abstract
Purpose: To investigate the utility of diffusion-weighted (DW) imaging in distinguishing bland thrombus from neoplastic thrombus in the portal vein in patients with hepatocellular carcinoma (HCC).
Materials and methods: In this retrospective institutional review board-approved HIPAA-complaint study, the imaging results in 25 patients (16 men [average age, 62.3 years; range, 35-75 years] and nine women [average age, 58.4 years; range, 32-69 years]; overall average age, 60.1 years; range, 32-75 years) with HCC and portal vein thrombosis who were examined with both contrast material-enhanced computed tomography (CT) and 1.5-T magnetic resonance (MR) imaging were reviewed. Axial echo-planar two-dimensional DW imaging was performed by using b values of 50, 400, and 800 sec/mm(2). A thrombus was considered neoplastic if it expanded the vessel or enhanced on the dynamic CT and MR images; otherwise it was considered bland. The signal intensity (SI) of the thrombus and HCC lesions in the same patients was compared on DW images. The results were evaluated by using the Fisher exact test. The apparent diffusion coefficients (ADCs) of HCC and thrombus were used to compute the ratio of the ADC of the thrombus to the ADC of the tumor.
Results: On DW images, 15 of 19 neoplastic thrombi demonstrated same SI and four showed lower SI than the primary HCC. Each of the six bland thrombi had lower SI than the primary HCC (P < .001). The mean ADC of HCC and thrombus in the neoplastic thrombus group was 0.87 x 10(-3) mm(2)/sec and 0.88 x 10(-3) mm(2)/sec, respectively (P = .45). The ADC of the bland thrombus was 2.89 x 10(-3) mm(2)/sec, significantly higher than the ADC of the HCC (1.0 x 10(-3) mm(2)/sec, P < .0003). The ratio of the ADC of the thrombus to the ADC of the tumor in the bland thrombus group was 2.9 compared with 0.998 in the neoplastic group (P = .0003).
Conclusion: DW imaging enables discrimination between bland and neoplastic portal vein thrombi when the ratio of the ADC of the thrombus to the ADC of HCC was lower than 2 and when the thrombi showed similar SI as the primary HCC when qualitative analysis was performed.
Comment in
-
Limited value of diffusion-weighted MR imaging for differentiating bland from malignant portal venous thrombi.Radiology. 2010 Aug;256(2):673-4; author reply 674. doi: 10.1148/radiol.100277. Radiology. 2010. PMID: 20656851 No abstract available.
Similar articles
-
Limited value of diffusion-weighted MR imaging for differentiating bland from malignant portal venous thrombi.Radiology. 2010 Aug;256(2):673-4; author reply 674. doi: 10.1148/radiol.100277. Radiology. 2010. PMID: 20656851 No abstract available.
-
Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging.Radiology. 2010 Jun;255(3):815-23. doi: 10.1148/radiol.10091706. Radiology. 2010. PMID: 20501719
-
Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients.AJR Am J Roentgenol. 2013 Dec;201(6):1211-9. doi: 10.2214/AJR.12.10171. AJR Am J Roentgenol. 2013. PMID: 24261359
-
Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.World J Gastroenterol. 2015 Aug 28;21(32):9457-60. doi: 10.3748/wjg.v21.i32.9457. World J Gastroenterol. 2015. PMID: 26327753 Free PMC article. Review.
-
Magnetic resonance diffusion-weighted imaging: extraneurological applications.Radiol Med. 2006 Apr;111(3):392-419. doi: 10.1007/s11547-006-0037-0. Epub 2006 Apr 11. Radiol Med. 2006. PMID: 16683086 Review. English, Italian.
Cited by
-
Hepatocellular carcinoma with macrovascular invasion: multimodality imaging features for the diagnosis.Diagn Interv Radiol. 2020 Nov;26(6):531-540. doi: 10.5152/dir.2020.19569. Diagn Interv Radiol. 2020. PMID: 32990243 Free PMC article.
-
Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.Curr Oncol. 2022 Jan 30;29(2):698-723. doi: 10.3390/curroncol29020061. Curr Oncol. 2022. PMID: 35200560 Free PMC article. Review.
-
Infiltrative non-mass-like hepatocellular carcinoma initially presenting with isolated malignant portal vein thrombosis: A case report and review of the literature.J Ultrason. 2020;20(80):e55-e60. doi: 10.15557/JoU.2020.0009. Epub 2020 Mar 31. J Ultrason. 2020. PMID: 32320167 Free PMC article.
-
Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis.Eur Radiol. 2020 May;30(5):2871-2880. doi: 10.1007/s00330-019-06649-z. Epub 2020 Feb 4. Eur Radiol. 2020. PMID: 32020403 Free PMC article.
-
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.Radiology. 2014 Oct;273(1):30-50. doi: 10.1148/radiol.14132362. Radiology. 2014. PMID: 25247563 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical